Biomarker Guided Treatment in DLBCL

NCT04025593 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Ibrutinib
DRUG: Lenalidomide
DRUG: chidamide
DRUG: decitabine

Sponsor

Ruijin Hospital